SEQUASE XR cpr ret 300 mg 100 pce
7680632550079
CH-63255
N05AH04
01.05.0.
Reimbursement limitations:
SEQUASE XR
- Traitement de la schizophrénie (traitement aigu et prévention des récidives).
- Traitement des épisodes …
1 / 3
google
Details
- Product number
- 6325504
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- quetiapinum 300 mg ut quetiapini fumaras, excipiens pro compresso obducto.
Articles (1)
Sequase XR 300 mg, Retardtabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
Reimbursement information
Public price
CHF 198.40
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2015
Authorization holder
Cheplapharm Schweiz GmbH
4102 Binningen
Authorization information
- Swissmedic authorization number
- 63255
- Drug name
- Sequase XR, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05AH04
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 01/10/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SEQUASE XR cpr ret 300 mg 100 pce
- Description (DE)
- SEQUASE XR Ret Tabl 300 mg 100 Stk
- Market launch
- 01/10/2013
- Narcotic (BTM)
- No